WINDY MITCHELL: Open Payments
NPI 1487613667 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 98 payments from 29 companies in 2025. Trend: 2023 $2,607 · 2024 $1,469 · 2025 $2,514
Food & beverage: $1,577Long term medical supply or device loan: $598Education: $339
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $598 |
| E.R. Squibb & Sons, L.L.C. | 14 | $177 |
| Genentech USA, Inc. | 13 | $177 |
| Janssen Biotech, Inc. | 11 | $150 |
| Merck Sharp & Dohme LLC | 7 | $149 |
| ABBVIE INC. | 3 | $123 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| SEAGEN INC. | 1 | $99 |
Products named: KISQALI, KEYTRUDA, LIBTAYO, RYBREVANT, OPDIVO, Enhertu, Lenvima, IMBRUVICA.
Industry payments across NY — which companies pay providers there.
